IT1238011B - Composizioni farmaceutiche a base di inibitori della riduttasi del hmg-coa per il trattamento della ipertrofia prostatica benigna. - Google Patents
Composizioni farmaceutiche a base di inibitori della riduttasi del hmg-coa per il trattamento della ipertrofia prostatica benigna.Info
- Publication number
- IT1238011B IT1238011B IT04865889A IT4865889A IT1238011B IT 1238011 B IT1238011 B IT 1238011B IT 04865889 A IT04865889 A IT 04865889A IT 4865889 A IT4865889 A IT 4865889A IT 1238011 B IT1238011 B IT 1238011B
- Authority
- IT
- Italy
- Prior art keywords
- hmg
- treatment
- prostatic hypertrophy
- pharmaceutical composition
- coa reductase
- Prior art date
Links
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 title abstract 3
- 208000004403 Prostatic Hyperplasia Diseases 0.000 title abstract 3
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 title 1
- 206010051482 Prostatomegaly Diseases 0.000 title 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 210000002307 prostate Anatomy 0.000 title 1
- CABVTRNMFUVUDM-VRHQGPGLSA-N (3S)-3-hydroxy-3-methylglutaryl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C[C@@](O)(CC(O)=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 CABVTRNMFUVUDM-VRHQGPGLSA-N 0.000 abstract 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- 201000004240 prostatic hypertrophy Diseases 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 239000003638 chemical reducing agent Substances 0.000 abstract 1
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000004907 gland Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000000877 morphologic effect Effects 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT04865889A IT1238011B (it) | 1989-12-13 | 1989-12-13 | Composizioni farmaceutiche a base di inibitori della riduttasi del hmg-coa per il trattamento della ipertrofia prostatica benigna. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT04865889A IT1238011B (it) | 1989-12-13 | 1989-12-13 | Composizioni farmaceutiche a base di inibitori della riduttasi del hmg-coa per il trattamento della ipertrofia prostatica benigna. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IT8948658A0 IT8948658A0 (it) | 1989-12-13 |
| IT8948658A1 IT8948658A1 (it) | 1991-06-13 |
| IT1238011B true IT1238011B (it) | 1993-06-21 |
Family
ID=11267879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT04865889A IT1238011B (it) | 1989-12-13 | 1989-12-13 | Composizioni farmaceutiche a base di inibitori della riduttasi del hmg-coa per il trattamento della ipertrofia prostatica benigna. |
Country Status (1)
| Country | Link |
|---|---|
| IT (1) | IT1238011B (it) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004026300A1 (en) * | 2002-09-17 | 2004-04-01 | Pfizer Limited | COMBINATIONS OF ATORVASTATIN AND α1, ADRENERGIC RECEPTOR ANTAGONISTS |
| WO2005089804A3 (en) * | 2004-03-16 | 2006-05-18 | Pfizer Ltd | Combinations of hmg-coa reductase inhibitors and alpha1 adrenergic receptor antagonists |
-
1989
- 1989-12-13 IT IT04865889A patent/IT1238011B/it active IP Right Grant
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004026300A1 (en) * | 2002-09-17 | 2004-04-01 | Pfizer Limited | COMBINATIONS OF ATORVASTATIN AND α1, ADRENERGIC RECEPTOR ANTAGONISTS |
| WO2005089804A3 (en) * | 2004-03-16 | 2006-05-18 | Pfizer Ltd | Combinations of hmg-coa reductase inhibitors and alpha1 adrenergic receptor antagonists |
Also Published As
| Publication number | Publication date |
|---|---|
| IT8948658A0 (it) | 1989-12-13 |
| IT8948658A1 (it) | 1991-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE319447T1 (de) | Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen | |
| EA200000220A1 (ru) | Сочетание ингибитора тирозинкиназы и химической стерилизации для лечения рака предстательной железы | |
| GEP20012578B (en) | (54) Heteroaryl Succinamides, Pharmaceutical Compositions Containing the Same and Methods for Treatment of the Diseases Caused by Metalloproteinase Activity | |
| ATE269066T1 (de) | Kombinationstherapie zur prophylaxe und/oder behandlung von gutartiger prostatischer hyperplasie | |
| DE69531457D1 (en) | Sulfonamide | |
| EE05025B1 (et) | Fumaarhappe derivaadid kasutamiseks transplantaadivastase reaktsiooni raviks | |
| BR0110420A (pt) | Agonistas muscarìnicos | |
| TR200100774T2 (tr) | Bir aP2 önleyicisinin ve kombinasyonunun kullanıldığı aterosklerozis tedavi yöntemi | |
| TR199901604T2 (xx) | Tedavide yararl� kinolin ve kinazolin bile�ikleri. | |
| AU6045398A (en) | Androgen synthesis inhibitors | |
| WO1999046279A3 (en) | INHIBITORS OF TYPE 5 AND TYPE 3 17β-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE | |
| NO20015790D0 (no) | Androstenderivater | |
| DE69323213D1 (de) | Kombination eines Hemmers der Cholesterin-Biosynthese und eines beta-laktamischem Hemmers der Cholesterinabsorption | |
| NO20002440D0 (no) | Hydroksam- og karboksylsyrederivater med MMP- og TNF- inhiberende aktivitet | |
| EP0793489A4 (en) | AGENTS FOR TREATING SKIN DISEASES | |
| ATE156839T1 (de) | Neue delta-17 und delta-20 ungesätigte und gesatigte 17--g(b)-substituierte-4-aza-5-g(a)- androstan-3-on verbindungen als inhibitoren von 5-alpha-reductase | |
| KR950031060A (ko) | 골다공증 치료용 약제학적 조성물 | |
| MY118986A (en) | Use of (alpha)-1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia | |
| AU1023497A (en) | Tissue factor - kunitz domain fusion proteins as factor viia inhibitors | |
| PL356780A1 (en) | Novel compounds | |
| IL137489A0 (en) | Pharmaceutical compositions containing inhibitors of the lymphotoxin pathway | |
| IT1238011B (it) | Composizioni farmaceutiche a base di inibitori della riduttasi del hmg-coa per il trattamento della ipertrofia prostatica benigna. | |
| ATE211921T1 (de) | Verwendung von gonadotropin zur behandlung der gestartigen hypertrophie der prostata | |
| HUP0100048A3 (en) | Arylsubstituted piperazine-derivatives, useful in the treatement of benign prostatic hyperlasia use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them | |
| EA199901043A1 (ru) | ИНГИБИТОРЫ ФАРНЕЗИЛТРАНСФЕРАЗЫ В КОМБИНАЦИИ С ИНГИБИТОРАМИ HMG-CoA-РЕДУКТАЗЫ ДЛЯ ЛЕЧЕНИЯ РАКА |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0001 | Granted | ||
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19961223 |